-
公开(公告)号:US09762403B2
公开(公告)日:2017-09-12
申请号:US14549930
申请日:2014-11-21
申请人: Avaya Inc.
IPC分类号: H04L12/18 , H04L12/721 , H04L12/761
摘要: A method apparatus and computer readable medium for preforming SPB-PIM multicast interactions is presented. A Backbone Edge Bridge (BEB) in a Shortest Path Bridging (SPB) network discovers a multicast stream originating within a Protocol-Independent Multicast (PIM) network. The BEB sends multicast information to a Rendezvous Point (RP) in the PIM network. The BEB advertises a multicast stream learned from the RP into the SPB network. The BEB receives an update that includes a receiver interest in said multicast stream and initiates PIM join procedures for permitting the receiver to receive the multicast stream.
-
公开(公告)号:US09742588B2
公开(公告)日:2017-08-22
申请号:US14226805
申请日:2014-03-26
发明人: Susan E. Carrie
CPC分类号: H04L12/467 , H04L12/4641 , H04L61/10
摘要: Methods and systems for selectively processing VLAN traffic from different networks while allowing flexible VLAN identifier assignment are disclosed. According to one aspect, a layer 2 switch includes a virtual switch identifier data structure that associates a VLAN identifier extracted from a layer 2 frame and a port identifier corresponding to a port on which a frame is received with a virtual switch identifier. The virtual switch identifier is used to select a per-virtual-switch data structure, such as a forwarding table. The per-virtual-switch data structure is used to control processing of the layer 2 frame on a per-virtual-switch basis. The per-virtual-switch data structure may also be updated separately from the data structures assigned to other virtual switches.
-
公开(公告)号:US09739744B2
公开(公告)日:2017-08-22
申请号:US14744267
申请日:2015-06-19
发明人: Jonathan C. Javitt , John R. Dwyer, Jr. , Thomas Y. S. Shen , Benjamin Cheng Yu Shen , Ching-Yuan Chu
IPC分类号: G01N27/327 , A61B5/145 , G06F19/00 , G01N33/487 , H04B1/3827 , A61B5/00 , A61B5/15
CPC分类号: G01N27/3273 , A61B5/0022 , A61B5/14532 , A61B5/150022 , A61B5/150358 , A61B5/150793 , A61B5/150854 , A61B5/7435 , A61B5/7465 , A61B2560/0252 , A61B2560/0266 , A61B2562/182 , G01N27/3274 , G01N33/48792 , G06F19/00 , G06F19/3418 , G16H10/60 , G16H50/20 , H04B1/3833
摘要: A patient monitoring network pertaining to blood glucose and other analyte measurements includes wireless blood glucose or other analyte measuring devices and a networked computer or server. Each monitoring device is associated with a patient and is configured to measure the glucose level or other analyte from a given blood sample via inserted test strips, transmit the measurements to the networked computer, and display received messages. The blood glucose monitoring device includes means for substantially reducing factors that could affect the glucose measurement such as thermal and RF interference.
-
公开(公告)号:US09736524B2
公开(公告)日:2017-08-15
申请号:US13345119
申请日:2012-01-06
IPC分类号: G06K7/00 , G06K9/20 , H04N21/2187 , H04N21/236 , H04N21/4223 , H04N21/4722 , H04N21/23 , H04N21/235 , H04N21/258 , H04N21/4725 , H04N21/45 , H04N21/25 , H04N21/254 , H04N21/47 , H04N21/414 , H04N21/442 , H04N21/478
CPC分类号: H04N21/4223 , H04N21/2187 , H04N21/23 , H04N21/235 , H04N21/25 , H04N21/2542 , H04N21/258 , H04N21/41407 , H04N21/44218 , H04N21/4524 , H04N21/4532 , H04N21/47 , H04N21/4722 , H04N21/4725 , H04N21/47815
摘要: The present disclosure provides user interface methods of and systems for displaying at least one available action overlaid on an image, comprising displaying an image; selecting at least one action and assigning a ranking weight thereto based on at least one of (1) image content, (2) current device location, (3) location at which the image was taken, (4) date of capturing the image; (5) time of capturing the image; and (6) a user preference signature representing prior actions chosen by a user and content preferences learned about the user; and ranking the at least one action based on its assigned ranking weight.
-
公开(公告)号:US09718883B2
公开(公告)日:2017-08-01
申请号:US14923655
申请日:2015-10-27
发明人: Vahe Bedian , Madhav Narasimha Devalaraja , Ian Foltz , Mary Haak-Frendscho , Sirid-Aimee Kellermann , Joseph Edwin Low , James Leslie Mobley
IPC分类号: C07K16/24 , A61K39/00 , A61K39/395 , A61K38/19
CPC分类号: C07K16/243 , A61K38/193 , A61K39/395 , A61K2039/505 , C07K16/24 , C07K2317/14 , C07K2317/21 , C07K2317/56 , C07K2317/565 , C07K2317/73 , C07K2317/76 , C07K2317/92 , G06Q30/02 , G06Q30/0601 , G06Q40/04 , G06Q50/12 , Y02A50/412
摘要: The present invention relates to antibodies and antigen-binding portions thereof that specifically bind to a M-CSF, preferably human M-CSF, and that function to inhibit a M-CSF. The invention also relates to human anti-M-CSF antibodies and antigen-binding portions thereof. The invention also relates to antibodies that are chimeric, bispecific, derivatized, single chain antibodies or portions of fusion proteins. The invention also relates to isolated heavy and light chain immunoglobulins derived from human anti-M-CSF antibodies and nucleic acid molecules encoding such immunoglobulins. The present invention also relates to methods of making human anti-M-CSF antibodies, compositions comprising these antibodies and methods of using the antibodies and compositions for diagnosis and treatment. The invention also provides gene therapy methods using nucleic acid molecules encoding the heavy and/or light immunoglobulin molecules that comprise the human anti-M-CSF antibodies. The invention also relates to transgenic animals and transgenic plants comprising nucleic acid molecules of the present invention.
-
公开(公告)号:US09695232B2
公开(公告)日:2017-07-04
申请号:US14431745
申请日:2012-10-03
申请人: Philogen S.p.A.
CPC分类号: C07K16/18 , A61K38/06 , A61K38/07 , A61K38/08 , A61K38/2066 , A61K39/3955 , A61K47/6843 , C07K2317/565 , C07K2317/622 , C07K2317/626 , A61K2300/00
摘要: Specific binding members that bind the ED-A isoform of fibronectin for use in methods of treatment, diagnosis, detection and/or imaging of inflammatory bowel disease (IBD), and/or for use in delivery to the IBD tissue of a molecule conjugated to the specific binding member. The specific binding member may, for example, be conjugated to an immunosupressive or anti-inflammatory molecule, such as interleukin-10.
-
公开(公告)号:US09686595B2
公开(公告)日:2017-06-20
申请号:US15087634
申请日:2016-03-31
申请人: Rovi Guides, Inc.
IPC分类号: H04N5/445 , H04N21/81 , H04N21/482 , H04N21/422 , H04N21/4415 , H04N21/462 , H04N21/439 , H04N21/4722 , H04N21/488
CPC分类号: H04N21/8106 , H04N21/42207 , H04N21/4221 , H04N21/42222 , H04N21/439 , H04N21/4415 , H04N21/4622 , H04N21/4722 , H04N21/482 , H04N21/4821 , H04N21/4825 , H04N21/488 , H04N2005/44556
摘要: Systems and methods for providing audio-based guidance features are provided. A guidance application may provide listings displays having listings for audio-friendly content. The listings may be indicated as listings for audio-friendly content. The guidance application may provide displays dedicated to listings for audio-friendly content. The guidance application provides audio-prompts describing display screens. The guidance application may determine a user's identity from a voice command and provide personalized guidance features.
-
公开(公告)号:US09668025B2
公开(公告)日:2017-05-30
申请号:US15064213
申请日:2016-03-08
申请人: Rovi Guides, Inc.
发明人: Kenneth F. Carpenter, Jr. , Johnny B. Corvin , Bryan M. Drummond , Michael D. Ellis , Edward B. Knudson , Jeffrey B. Rush , Toby DeWeese
IPC分类号: H04N21/482 , H04N5/445 , H04N21/462 , H04N21/431 , H04N5/45 , H04N5/50
CPC分类号: H04N21/4821 , H04N5/44543 , H04N5/45 , H04N5/50 , H04N21/4312 , H04N21/4316 , H04N21/4622 , H04N21/482
摘要: An interactive television application with mosaic browsing is provided. Selectable cells that may be associated with entities are used to display information corresponding to the entities. Information may include brand marks such as logos or any other suitable entity identifier. A cell may be in focus or it may not be in focus. When a cell is in focus the information displayed in the cell may be different than the information displayed when the cell is not in focus. Users may navigate among cells. The cells may be grouped into regions based on, for example, their association with similar entities.
-
公开(公告)号:US09658309B2
公开(公告)日:2017-05-23
申请号:US13522937
申请日:2011-01-19
CPC分类号: G01S5/02 , G01S5/0221 , G01S5/0226 , G01S5/0252 , H04W4/04 , H04W4/043
摘要: Systems and methods for locating an object are disclosed herein. The locator system includes a plurality of reference units and a processor in communication with the reference units. The reference units are positioned about a region in which a mobile unit is located, and each reference unit includes a transceiver for transmitting and receiving a transaction-based location signal to and from the mobile unit. The processor is configured for estimating time offsets between the mobile unit and reference units and aligning the transaction-based location signals from the reference units by removing the time offsets. The processor is further configured for collectively processing data representative of the aligned location signals based on a plurality of potential locations to identify at least one of the potential locations as a likely mobile unit location.
-
公开(公告)号:US09650336B2
公开(公告)日:2017-05-16
申请号:US14350729
申请日:2012-10-10
申请人: ASTRAZENECA AB
发明人: Anna Minidis , Fredrik Rahm , Jenny Viklund
IPC分类号: A61K31/40 , A61K31/44 , C07D209/96 , C07D209/54 , C07D401/10 , C07D403/10 , C07D491/107 , C07D207/34 , A61K31/403 , A61K31/407 , A61K31/4439 , A61K31/506 , A61K45/06 , C07D401/04 , C07D403/04
CPC分类号: C07D209/54 , A61K31/403 , A61K31/407 , A61K31/4439 , A61K31/506 , A61K45/06 , C07D207/34 , C07D401/04 , C07D401/10 , C07D403/04 , C07D403/10 , C07D491/107
摘要: Beta-secretase inhibitors, of formula (I) as described in the specification, pharmaceutical compositions comprising them and therapeutic methods using them for the treatment and/or prevention of Aβ-related pathologies such as Down's syndrome, β-amyloid angiopathy such as but not limited to cerebral amyloid angiopathy or hereditary cerebral hemorrhage, disorders associated with cognitive impairment such as but not limited to MCI (“mild cognitive impairment”), Alzheimer's Disease, memory loss, attention deficit symptoms associated with Alzheimer's disease, neurodegeneration associated with diseases such as Alzheimer's disease or dementia including dementia of mixed vascular and degenerative origin, pre-senile dementia, senile dementia and dementia associated with Parkinson's disease, progressive supranuclear palsy or cortical basal degeneration.
-
-
-
-
-
-
-
-
-